• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA 365 INTRAGASTRIC BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA 365 INTRAGASTRIC BALLOON Back to Search Results
Model Number B-50012
Device Problems Separation Problem (4043); Premature Separation (4045)
Patient Problem Failure of Implant (1924)
Event Date 07/13/2023
Event Type  malfunction  
Manufacturer Narrative
Combined medwatch submitted to the fda on 15/aug/2023.A review of the device labeling notes the following: the current orbera¿ intragastric balloon system directions for use (dfu) addresses the known and anticipated potential events of difficulty with fill tube are as follows: warnings and precautions: proper positioning of the placement catheter assembly and the bib¿ system balloon within the stomach is necessary to allow proper inflation.Lodging of the balloon in the esophageal opening during inflation may cause injury and/or device rupture.The orbera¿ intragastric balloon system is composed of soft silicone elastomer and is easily damaged by instruments or sharp objects.The balloon must be handled only with gloved hands and with the instruments recommended in this document.Note: if the balloon becomes separated from the sheath prior to placement, do not attempt to use the balloon or reinsert the balloon into the sheath.Note: during the filling process the fill tube must remain slack.If the fill tube is under tension during the intubation process, the fill tube may dislodge from the balloon, preventing further balloon deployment.Warning: patients must be advised that the igb is intended to be placed for 6 months maximally, at which point removal is required.Longer periods of igb placement increase the risk of igb deflation (a reduction in size of the device due to loss of saline) which can lead to intestinal obstruction and risk for death.The risk of these events is also significantly higher when igbs are filled to a larger volume than indicated (greater than 700cc).Warning: when filling the igb during the placement procedure, avoid rapid fill rates as these will generate high pressure which can damage the igb valve or cause premature detachment of the igb from the tip of the placement catheter.The labeling is adequate as it addresses the reported complaint.Additional information: a device history record (dhr) review was required due to the complaint being mdr reportable.The subject product met all specifications and requirements in effect at the time of manufacture.There were no other complaints in the apollo database against this lot number.Af05524 and allegation.Device evaluation summary: (if final report with completed investigation) the device was returned to the apollo device analysis laboratory on 08/aug/2023.A non-inflated balloon with the fill tip disconnected from the valve was returned.The sheath is present on the shell.The fill tip was reconnected into the valve and the end of the balloon was clamped onto the pull force equipment and it met the minimum requirements.The fill tip pressure to inflate the balloon met the minimum requirements.Once inflated, an air leak test was performed on the device, and the sheath broke away as intended and there were no leaks.The balloon was then submerged in water and there were no leaks from the valve.A pin gauge was used to check the circumference of the fill tube tip and it met specifications.The complaint could not be verified as the device performed as intended once the fill tip was reconnected.
 
Event Description
Healthcare professional reported valve was in a bad state and the balloon could not be filled.Procedure not completed with backup device and was rescheduled.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA 365 INTRAGASTRIC BALLOON
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s. capital of texas hwy
bldg. 1 ste. 300
austin TX 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA, SRL
coyol free zone
bldg b 13.3
alajuela, cs CRI
CS   CRI
Manufacturer Contact
adriana russell
1120 s. capital of texas hwy
bldg. 1 ste. 300
austin, TX 78746
5122795114
MDR Report Key17549700
MDR Text Key321374183
Report Number3006722122-2023-00159
Device Sequence Number1
Product Code LTI
UDI-Device Identifier10811955020725
UDI-Public(01)10811955020725(17)20250331(10)AF05524
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberB-50012
Device Catalogue NumberB-50012
Device Lot NumberAF05524
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/08/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/14/2023
Initial Date FDA Received08/15/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/31/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age64 YR
Patient SexMale
-
-